Pharmaceutical Executive
October 01, 2011
Issue PDF
0
0
Thirty Years of Pharm Exec
October 01, 2011
Profiles
0
0
Fred Frank, Vice Chairman, P.J. Solomon Co.
October 01, 2011
Profiles
0
0
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
October 01, 2011
Features
0
0
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
October 01, 2011
Profiles
0
0
Atsushi Nagahisa, President & CEO, RaQualia
October 01, 2011
Profiles
0
0
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
October 01, 2011
Profiles
0
0
Henry Waxman, Congressional Representative from Los Angeles, California
October 01, 2011
Profiles
0
0
Harvey Bale, Jr., MD, former Director-General, IFPMA
October 01, 2011
Back Page
0
0
Top 10 Companies by Market Share
October 01, 2011
Profiles
0
0
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
October 01, 2011
Profiles
0
0
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
October 01, 2011
Profiles
0
0
Jane Henney, MD, Former FDA Commissioner
October 01, 2011
Profiles
0
0
P. Roy Vagelos, MD, Chairman Emeritus, Merck
October 01, 2011
Features
0
0
Success in the emerging markets depends significantly on navigating the myths and mental traps.
October 01, 2011
Features
0
0
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
October 01, 2011
From the Editor
0
0
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
October 01, 2011
Profiles
0
0
Francis Collins, MD, PhD, Director, National Institutes of Health
October 01, 2011
Profiles
0
0
Abbey Meyers, Founder, National Organization of Rare Disorders
October 01, 2011
Profiles
0
0
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
October 01, 2011
Profiles
0
0
Martin Wygod, Chairman, WebMD
October 01, 2011
Profiles
0
0
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
October 01, 2011
Back Page
0
0
30 Years of Pharma: Perspective in Numbers
October 01, 2011
Profiles
0
0
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
October 01, 2011
Profiles
0
0
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
October 01, 2011
Back Page
0
0
Top 10 Products Worldwide
October 01, 2011
Profiles
0
0
Josef von Rickenbach, President & CEO, Parexel
October 01, 2011
Profiles
0
0
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
October 01, 2011
Profiles
0
0
Fernand Sauer, First Director General, European Medicines Agency
October 01, 2011
Profiles
0
0
Antonio Gotto, MD, Dean, Weill Cornell Medical College
October 01, 2011
Profiles
0
0
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
October 01, 2011
Profiles
0
0
Henry Grabowski, PhD, Professor of Economics, Duke University
October 01, 2011
0
0
Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.
October 01, 2011
Profiles
0
0
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
October 01, 2011
Profiles
0
0
Andrew Witty, Chairman & CEO, GlaxoSmithKline
October 01, 2011
Back Page
0
0
Three Decades of Politics and Pop Culture ... on Drugs